Propranolol in Primary Progressive Aphasia

Recruiting Early Phase 1 Interventional Study
Aphasia, Primary Progressive
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of Missouri-Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to find out how the language of people with Primary Progressive Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure. This research is being done because there are currently no drug treatment options for language imp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 1\. Age: 50 and older * 2\. Primary Progressive Aphasia diagnosis * 3\. Native English speaker Exclusion Criteria: * 1\. Unable to provide consent * 2\. Taking alpha 2 agonists (clonidine and guanfacine) * 3\. Other major psychological or neurological diagnosis * 4\. Major h…
Contacts

David Beversdorf, MD

573-882-6081

beversdorfd@health.missouri.edu

CONTACT

Kim Ray

573-882-0515

raykk@health.missouri.edu

CONTACT